3 medical AI systems clear regulatory hurdles
The last two weeks saw market clearances granted in Europe for AI-based software focused on remote patient monitoring, prostate oncology and real-time guidance of coronary stenting.
Company announcements:
Biobeat’s AI-powered remote patient monitoring platform receives a full CE mark (May 4)
Exini Diagnostics receives CE mark clearance for AI-powered quantitative assessment of prostate-specific membrane antigen (May 3)
Abbott’s new coronary imaging platform powered by artificial intelligence launches in Europe (April 26)